Breaking Down A Potentially Novel Treatment For Cancer
Today, we had a Zoom meeting with Anthony Cataldo, Chairman, Chief Executive Officer & President of immuno-oncology company GT [...]
AnaptysBio (ANAB) Probability Sentiment
Anaptysbio, Inc. (NASDAQ:ANAB) Probability Sentiment SUMMARY Novel antibodies remain a top choice among researchers to [...]
Xenon Pharmaceuticals (XENE) Probability Sentiment
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Probability Sentiment FEATURED CATALYST SUMMARY Recent advances in treating epilepsy, such [...]
SanaCurrents holding BioCryst (BCRX) shares into December 3 PDUFA
The FDA will decide on December 3 whether to approve BioCryst Pharmaceuticals’ (NASDAQ:BCRX) Orladeyo (berotralstat) to treat hereditary angioedema (HAE), [...]
SanaCurrents closing out Adverum Biotechnologies (ADVM)
Adverum Biotechnologies (NASDAQ:ADVM) on Saturday reported positive results from its phase II Optic trial testing its gene therapy drug ADVM-022 [...]
Adverum catalyst set for Saturday, November 14
Adverum Biotechnologies (NASDAQ:ADVM) said it will present additional clinical data for cohorts 1-4 in the OPTIC phase I clinical trial [...]
Calliditas’ Shares Soar About 35% After Hitting Catalyst
Sweden-based Calliditas Therapeutics’ (NASDAQ:CALT) delivered on its phase III trial of Nefecon to treat Berger’s disease, or primary IgA Nephropathy [...]
Annexon, Inc. (ANNX) Probability Sentiment
$ANNX Probability Sentiment FEATURED CATALYST SUMMARY Huntington’s disease (HD) afflicts an estimated 3 to 7 [...]